Literature DB >> 10585712

Prospects for the use of nuclear transfer in human transplantation.

R P Lanza1, J B Cibelli, M D West.   

Abstract

The successful application of nuclear transfer techniques to a range of mammalian species has brought the possibility of human therapeutic cloning significantly closer. The objective of therapeutic cloning is to produce pluripotent stem cells that carry the nuclear genome of the patient and then induce them to differentiate into replacement cells, such as cardiomyocytes to replace damaged heart tissue or insulin-producing beta cells for patients with diabetes. Although cloning would eliminate the critical problem of immune incompatibility, there is also the task of reconstituting the cells into more complex tissues and organs in vitro. In the review, we discuss recent progress that has been made in this field as well as the inherent dangers and scientific challenges that remain before these techniques can be used to harness genetically matched cells and tissues for human transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10585712     DOI: 10.1038/70709

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  18 in total

1.  Can RNA interference be used to expand the plasticity of autologous adult stem cells?

Authors:  Boon Chin Heng; Tong Cao
Journal:  J Mol Med (Berl)       Date:  2004-09-14       Impact factor: 4.599

2.  Downregulation of transcription factors by ribonucleic acid interference. A novel approach to extend the multipotency of autologous adult stem cells?

Authors:  Boon C Heng; Tong Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 May-Jun       Impact factor: 2.416

3.  The topsy-turvy cloning law.

Authors:  Iain Brassington; Stuart Oultram
Journal:  Monash Bioeth Rev       Date:  2011-03

4.  Expression of a2, a5 and a6 subunits of integrin in de-differentiated NIH3T3 cells by cell-free extract of embryonic stem cells.

Authors:  Zohreh Mostafavi-Pour; Sarva Keihani; Tahereh Talaei-Khozani; Pooneh Mokaram; Majid Fardaei; Leili Rohani; Saeedeh Ebadat; Ahmadreza Sardarian
Journal:  Mol Biol Rep       Date:  2012-07       Impact factor: 2.316

Review 5.  Immune response to stem cells and strategies to induce tolerance.

Authors:  Puspa Batten; Nadia A Rosenthal; Magdi H Yacoub
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

6.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

7.  Isolation of murine embryonic stem and embryonic germ cells by selective ablation.

Authors:  Ed J Gallagher; Peter Lodge; Ray Ansell; Jim McWhir
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

8.  Human embryonic stem cells derived by somatic cell nuclear transfer.

Authors:  Masahito Tachibana; Paula Amato; Michelle Sparman; Nuria Marti Gutierrez; Rebecca Tippner-Hedges; Hong Ma; Eunju Kang; Alimujiang Fulati; Hyo-Sang Lee; Hathaitip Sritanaudomchai; Keith Masterson; Janine Larson; Deborah Eaton; Karen Sadler-Fredd; David Battaglia; David Lee; Diana Wu; Jeffrey Jensen; Phillip Patton; Sumita Gokhale; Richard L Stouffer; Don Wolf; Shoukhrat Mitalipov
Journal:  Cell       Date:  2013-05-15       Impact factor: 41.582

Review 9.  Reprogramming cells for transplantation.

Authors:  Jonathan Leor; Alexander Battler; Robert A Kloner; Sharon Etzion
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

10.  Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.

Authors:  Johnson Rajasingh; Erin Lambers; Hiromichi Hamada; Evelyn Bord; Tina Thorne; Ilona Goukassian; Prasanna Krishnamurthy; Kenneth M Rosen; Deepali Ahluwalia; Yan Zhu; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  Circ Res       Date:  2008-05-15       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.